Preventative Maintenance/Service Contract for Seventeen (17) ChemoMetec NC-202 Instruments
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health Clinical Center plans to award a sole-source, firm-fixed-price contract to ChemoMetec, Inc. for annual preventative maintenance and service support of seventeen proprietary NC-202 instruments used in FDA-regulated cell therapy manufacturing at the Center for Cellular Engineering. These instruments are essential for patient-specific therapy production and must remain in validated operating condition to comply with current Good Manufacturing Practices and ensure uninterrupted patient care. The scope of work includes preventative maintenance, calibration, software updates and patches, inspections, troubleshooting, repair support, and replacement of proprietary service parts, all of which require manufacturer-specific tools, software access, and expertise only ChemoMetec can provide. The contract covers seventeen specific instruments identified by serial number and is justified under FAR 13.106-1(b)(1)(i) due to the proprietary nature of the equipment and the absence of alternative sources capable of maintaining regulatory compliance and operational integrity. Failure to use authorized service could result in manufacturing interruptions, regulatory noncompliance, and costly requalification efforts. While the notice does not solicit competing bids, responsible parties may submit capability statements by August 13, 2026, to be considered, though the government retains full discretion to proceed without competition. All services will be performed at the NIH Clinical Center in Bethesda, Maryland, and inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Title: Preventative Maintenance/Service Contract for Seventeen (17) ChemoMetec NC-202 Instruments
Notice ID (POTS): 26-007432
Product Service Code (PSC): J066 – Maintenance, Repair, and Rebuilding of Instruments and Laboratory Equipment
NAICS Code: 811210 – Electronic and Precision Equipment Repair and Maintenance
Place of Performance: National Institutes of Health
Clinical Center
Bethesda, MD 20892
Notice
The National Institutes of Health (NIH) Clinical Center intends to award a sole-source firm-fixed-price purchase order to ChemoMetec, Inc. for annual preventative maintenance and service support for seventeen (17) ChemoMetec NC-202 instruments used by the Center for Cellular Engineering (CCE) in FDA-regulated cell therapy manufacturing operations.
Requirement
The NC-202 instruments are critical analytical devices used in the manufacture and testing of patient-specific cell therapies. The contractor shall provide annual preventative maintenance, calibration, software updates and patches, inspections, troubleshooting, repair support, replacement of proprietary service parts, and technical support necessary to maintain validated operating conditions for all seventeen (17) instruments. These services are required to maintain compliance with FDA current Good Manufacturing Practice (cGMP) requirements and ensure uninterrupted patient care.
The serial numbers covered under this action are as follows: 9002020042302432, 9002020042302431, 9002020042302427, 9002020042302422, 9002020042302424, 9002020042302414,9002020042302421, 9002020042302425, 9002020042302426, 9002020042302413, 9002020042302412, 9002020042302435, 9002020042302411,9002020042302436, 9002020042302434, 9002020042302423 and 9002020042302429.
Sole-Source Rationale
The NC-202 instruments are proprietary systems manufactured by ChemoMetec. Preventative maintenance, calibration, software updates, diagnostic testing, replacement parts, and technical support require proprietary tools, software access, and manufacturer-authorized expertise available only from ChemoMetec. Failure to use authorized maintenance services could jeopardize validated manufacturing processes, interrupt patient treatment schedules, increase regulatory risk, and require costly requalification activities.
Authority
The intended sole-source acquisition is authorized under FAR 13.106-1(b)(1)(i), which permits solicitation from a single source when the Contracting Officer determines that only one source is reasonably available for an acquisition not exceeding the Simplified Acquisition Threshold.
Capability Statements
This notice is not a request for quotations or proposals. Responsible sources that believe they can satisfy the Government's requirement may submit a written capability statement. The Government will evaluate all capability statements received; however, the determination not to compete this requirement remains solely within the Government's discretion.
Submission Instructions
Capability statements shall reference POTS 26-007432 and must be submitted electronically no later than August 13, 2026, at 6:00 P.M. Eastern Time (ET).
Point of Contact
Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division
Office of Acquisitions and Logistics Management
National Institutes of Health
Email: shasheshe.goolsby@nih.gov
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency